ASCO® 2023 Insights: "Randomised Phase II Trial of Cabozantinib Combined With PD-1 & CTLA-4 Inhibition vs. Cabozantinib in Metastatic Soft Tissue Sarcoma"

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

ASCO® 2023 Insights: "Randomised Phase II Trial of Cabozantinib Combined With PD-1 & CTLA-4 Inhibition vs. Cabozantinib in Metastatic Soft Tissue Sarcoma"

By ecancer FEATURING Brian Van Tine

81 views

June 15, 2023

Comments 0

Patient Case Discussion on a Treatment Approach for Advanced Gastroi…

Feat. M. Agulnik

Treatment Approach for Advanced Gastrointestinal Stromal Tumor (GIST…

Feat. K. Polson

2024 Update in Sarcomas

Total Health

D. Portnoy

535 views

Developmental Therapeutics Highlights From ASCO® 2024

2024 ASCO® Annual Meeting Insights Hub

G. Sonpavde

531 views

Sarcoma 101: Multidisciplinary Approach, Therapies, and Future Direc…

Total Health

B. Wilky

224 views

ASCO® 2024 Highlights in Sarcomas

2024 ASCO® Annual Meeting Insights Hub

R. Jones

209 views

NCCN Clinical Practice Guidelines for Treating GIST

Andrea Napolitano

401 views

Gastrointestinal Stromal Tumors (GIST) and Resistance Mutations

Warren Chow

348 views

ESMO 2024 Summary: Highlights of Important Trials in Sarcoma

2024 ESMO Annual Meeting Insights Hub

R. Jones

143 views

ASCO® 2024 Highlights: Advances in GIST Tumors and Soft Tissue Sarco…

2024 ASCO® Annual Meeting Insights Hub

A. Hussein

151 views

Systemic Therapies for Uterine Leiomyosarcoma

OncoAlert

I. Ray-Coquard

334 views

What Is New in Treatment of Soft Tissue and Bone Sarcoma

ISCO - International School of Clinical Oncology

S. Stacchiotti

217 views

Divide and Conquer Sarcomas Through Precision Oncology

Miami Cancer Institute Precision Oncology Symposium

N. Somaiah

106 views

Multidisciplinary Management of Advanced Soft Tissue Sarcoma

i3 Health

S. Patel, B. Ruben, K. Polson

250 views

ESMO 2023 Insights: "Novel Combinations in Sarcomas"

Insights from 2023 ESMO Annual Meeting

R. Jones

245 views

Precision Oncology in the Diagnosis and Management of Sarcoma

University of Miami Sylvester Comprehensive Cancer Center

S. Bialick

71 views

INSIGHT: A Phase 3 Study of Ripretinib vs. Sunitinib in Pts With Adv…

Insights from 2024 ASCO® GI Annual Meeting

J. Zalcberg

186 views

ctDNA Analysis From INTRIGUE Study: Updated OS & Safety With Ripreti…

Insights from 2024 ESMO Sarcoma and Rare Cancers Congress

J. Blay

192 views

2023 West Oncology Conference: Soft Tissue Sarcoma Updates

2023 West Oncology Conference

B. Van Tine

514 views

Final Analyses From INTRIGUE: OS & Long-Term Safety With Ripretinib …

Insights from 2024 ASCO® GI Annual Meeting

J. Zalcberg

178 views

Sarcoma Panel Discussion: Molecular Tumor Board - Multidisciplinary …

University of Miami Sylvester Comprehensive Cancer Center

P. Seo, A. Rosenberg, P. Castillo, M. De La Fuente, S. Gultekin, E. Krill-Jackson, C. Gomez

75 views

ASCO® 2024 Insights: "PROs of the MEDISARC Study (AIO-STS-0415) - Du…

2024 ASCO® Annual Meeting Insights Hub

V. Grünwald

73 views

Login

Login

Join VuMedi

ASCO® 2023 Insights: "Randomised Phase II Trial of Cabozantinib Combined With PD-1 & CTLA-4 Inhibition vs. Cabozantinib in Metastatic Soft Tissue Sarcoma"

Patient Case Discussion on a Treatment Approach for Advanced Gastroi…

Treatment Approach for Advanced Gastrointestinal Stromal Tumor (GIST…

Recommended

2024 Update in Sarcomas

Developmental Therapeutics Highlights From ASCO® 2024

Sarcoma 101: Multidisciplinary Approach, Therapies, and Future Direc…

ASCO® 2024 Highlights in Sarcomas

NCCN Clinical Practice Guidelines for Treating GIST

Gastrointestinal Stromal Tumors (GIST) and Resistance Mutations

ESMO 2024 Summary: Highlights of Important Trials in Sarcoma

ASCO® 2024 Highlights: Advances in GIST Tumors and Soft Tissue Sarco…

Systemic Therapies for Uterine Leiomyosarcoma

What Is New in Treatment of Soft Tissue and Bone Sarcoma

Divide and Conquer Sarcomas Through Precision Oncology

Multidisciplinary Management of Advanced Soft Tissue Sarcoma

ESMO 2023 Insights: "Novel Combinations in Sarcomas"

Precision Oncology in the Diagnosis and Management of Sarcoma

INSIGHT: A Phase 3 Study of Ripretinib vs. Sunitinib in Pts With Adv…

ctDNA Analysis From INTRIGUE Study: Updated OS & Safety With Ripreti…

2023 West Oncology Conference: Soft Tissue Sarcoma Updates

Final Analyses From INTRIGUE: OS & Long-Term Safety With Ripretinib …

Sarcoma Panel Discussion: Molecular Tumor Board - Multidisciplinary …

ASCO® 2024 Insights: "PROs of the MEDISARC Study (AIO-STS-0415) - Du…